Scandent Imaging Ltd
BSE:516110
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Scandent Imaging Ltd
BSE:516110
|
IN |
|
F
|
Forbidden Spirits Distilling Corp
XTSX:VDKA
|
CA |
|
Westaim Corp
XTSX:WED
|
CA |
|
Furukawa Co Ltd
TSE:5715
|
JP |
|
J
|
JoulWatt Technology Co Ltd
SSE:688141
|
CN |
|
Dyaco International Inc
TWSE:1598
|
TW |
|
M
|
Mercator Medical SA
WSE:MRC
|
PL |
Balance Sheet
Balance Sheet Decomposition
Scandent Imaging Ltd
Scandent Imaging Ltd
Balance Sheet
Scandent Imaging Ltd
| Mar-2012 | Mar-2013 | Mar-2014 | Mar-2015 | Mar-2016 | Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||
| Cash & Cash Equivalents |
0
|
0
|
1
|
27
|
26
|
24
|
2
|
5
|
16
|
4
|
2
|
193
|
175
|
2
|
|
| Cash Equivalents |
0
|
0
|
1
|
27
|
26
|
24
|
2
|
5
|
16
|
4
|
2
|
193
|
175
|
2
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
3
|
5
|
83
|
64
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
0
|
0
|
1
|
0
|
0
|
25
|
41
|
90
|
215
|
290
|
340
|
20
|
|
| Accounts Receivables |
1
|
1
|
0
|
0
|
0
|
0
|
0
|
25
|
41
|
90
|
215
|
290
|
340
|
20
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
3
|
3
|
2
|
3
|
6
|
380
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
1
|
0
|
1
|
1
|
1
|
8
|
16
|
36
|
33
|
8
|
|
| Total Current Assets |
1
|
1
|
1
|
28
|
27
|
24
|
4
|
33
|
64
|
111
|
317
|
586
|
555
|
411
|
|
| PP&E Net |
0
|
0
|
0
|
17
|
18
|
30
|
81
|
87
|
96
|
81
|
69
|
70
|
60
|
40
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
13
|
18
|
12
|
12
|
12
|
87
|
85
|
9
|
|
| Total Assets |
1
N/A
|
1
-30%
|
1
-14%
|
45
+7 430%
|
46
+1%
|
55
+20%
|
99
+80%
|
138
+40%
|
171
+24%
|
204
+19%
|
398
+95%
|
746
+87%
|
700
-6%
|
461
-34%
|
|
| Liabilities | |||||||||||||||
| Accounts Payable |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
23
|
19
|
22
|
154
|
157
|
49
|
286
|
|
| Short-Term Debt |
1
|
0
|
4
|
6
|
6
|
1
|
0
|
1
|
28
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
12
|
22
|
33
|
35
|
32
|
|
| Other Current Liabilities |
0
|
1
|
0
|
0
|
1
|
13
|
45
|
8
|
6
|
20
|
25
|
31
|
17
|
4
|
|
| Total Current Liabilities |
1
|
1
|
4
|
6
|
6
|
14
|
46
|
32
|
53
|
53
|
200
|
221
|
101
|
322
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
2
|
55
|
67
|
43
|
21
|
10
|
2
|
2
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
5
|
2
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
17
|
35
|
55
|
8
|
0
|
|
| Total Liabilities |
1
N/A
|
1
-25%
|
4
+356%
|
6
+47%
|
6
+6%
|
14
+121%
|
49
+251%
|
88
+79%
|
121
+37%
|
113
-7%
|
256
+126%
|
288
+12%
|
116
-60%
|
326
+182%
|
|
| Equity | |||||||||||||||
| Common Stock |
30
|
30
|
30
|
321
|
321
|
321
|
321
|
321
|
321
|
321
|
321
|
540
|
540
|
540
|
|
| Retained Earnings |
30
|
30
|
34
|
282
|
282
|
280
|
271
|
271
|
271
|
230
|
179
|
82
|
44
|
406
|
|
| Total Equity |
0
N/A
|
0
N/A
|
4
-1 700%
|
39
N/A
|
39
+1%
|
41
+4%
|
50
+21%
|
50
+0%
|
50
+1%
|
91
+81%
|
142
+57%
|
458
+222%
|
584
+27%
|
135
-77%
|
|
| Total Liabilities & Equity |
1
N/A
|
1
-30%
|
1
-14%
|
45
+7 430%
|
46
+1%
|
55
+20%
|
99
+80%
|
138
+40%
|
171
+24%
|
204
+19%
|
398
+95%
|
746
+87%
|
700
-6%
|
461
-34%
|
|
| Shares Outstanding | |||||||||||||||
| Common Shares Outstanding |
3
|
3
|
3
|
32
|
32
|
32
|
32
|
32
|
32
|
35
|
35
|
54
|
54
|
54
|
|